Dales Remedies.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-07-2024
- Paid Up Capital ₹ 0.88 M
as on 01-07-2024
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.61 M
as on 01-07-2024
- Satisfied Charges ₹ 6.85 M
as on 01-07-2024
- Revenue -20.40%
(FY 2021)
- Profit 377.18%
(FY 2021)
- Ebitda 129.16%
(FY 2021)
- Net Worth 10.60%
(FY 2021)
- Total Assets 0.45%
(FY 2021)
About Dales Remedies.Ltd.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M.
The company currently has active open charges totaling ₹0.61 M. The company has closed loans amounting to ₹6.85 M, as per Ministry of Corporate Affairs (MCA) records.
Jyotsna Mulgaonkar and Tina Angirish serve as directors at the Company.
- CIN/LLPIN
U24239MH1992PTC064949
- Company No.
064949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dales Remedies.Ltd.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotsna Mulgaonkar  | Director | 01-Feb-2017 | Current |
| Tina Angirish | Director | 14-Feb-2004 | Current |
Financial Performance of Dales Remedies.Ltd..
Dales Remedies Pvt.Ltd., for the financial year ended 2021, experienced significant reduction in revenue, with a 20.4% decrease. The company also saw a substantial improvement in profitability, with a 377.18% increase in profit. The company's net worth Soared by an impressive increase of 10.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dales Remedies.Ltd.?
In 2021, Dales Remedies.Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Butterfly Home Decor Limited Liability P ArtnershipActive 13 years 1 monthTina Angirish is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Development Co-Op. Bank Ltd. Creation Date: 24 Mar 1994 | ₹0.61 M | Open |
Others Creation Date: 08 Jun 2017 | ₹2.50 M | Satisfied |
Bank Of Maharashtra Creation Date: 22 Apr 1999 | ₹0.75 M | Satisfied |
How Many Employees Work at Dales Remedies.Ltd.?
Dales Remedies.Ltd. has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dales Remedies.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dales Remedies.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
